Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

4SC and NKI collaborate to study neoadjuvant domatinostat in urothelial carcinoma

June 18, 2021

Modus collaborates with Imperial College London on clinical study of sevuparin in malaria

June 18, 2021

Apexigen and NSGO-CTU to collaborate on phase II study of sotigalimab for ovarian cancer

June 17, 2021

Debiopharm and Ubix collaborate to develop antibody degraducer conjugates

June 17, 2021

Mydecine launches in silico drug discovery program with University of Alberta

June 17, 2021

MacroGenics and Zai Lab collaborate on bispecific molecules in immuno-oncology

June 17, 2021

Servier and Oncodesign's collaboration in Parkinson's selects preclinical candidate

June 16, 2021

Harbour BioMed and Dana-Farber Cancer Institute to codevelop novel biotherapies for cancer

June 16, 2021

Linnaeus and Merck & Co. expand collaborative evaluation of LNS-8801 with Keytruda

June 16, 2021

CRISPR and Capsida enter strategic collaboration to develop gene-edited therapies

June 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...